| Bacillus anthracis |
Anthrax lethal factor |
Potency |
12589.3 |
nM |
None |
| Bacillus subtilis (strain 168) |
DNA polymerase III |
Potency |
29934.9 |
nM |
None |
| Bacteria |
DNA |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01938 |
| Bacteria |
DNA |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.01.010 |
| Bacteria |
DNA |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.02.041 |
| Bos taurus |
Bos taurus |
pKa |
7.4 |
None |
10.1021/jm00105a014 |
| Bos taurus |
Calf thymus DNA |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01938 |
| Bos taurus |
Calf thymus DNA |
EC50 |
11000.0 |
nM |
10.1016/0960-894X(96)00230-2 |
| Bos taurus |
Calf thymus DNA |
EC50 |
11000.0 |
nM |
10.1021/jm9708083 |
| Bos taurus |
Calf thymus DNA |
Inhibition |
nan |
% |
10.1016/j.bmc.2018.09.021 |
| Bos taurus |
Calf thymus DNA |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.9b00970 |
| Bos taurus |
Calf thymus DNA |
Kb |
1.36 |
10'5/M |
10.1016/j.bmc.2018.06.016 |
| Bos taurus |
Calf thymus DNA |
Kb |
1.36 |
10'5/M |
10.1016/j.ejmech.2016.03.066 |
| Bos taurus |
Calf thymus DNA |
Log K |
5.57 |
None |
10.1021/jm00137a009 |
| Bos taurus |
Calf thymus DNA |
Log K |
5.57 |
None |
10.1021/jm00159a035 |
| Bos taurus |
Calf thymus DNA |
Log K |
5.57 |
None |
10.1021/jm00387a012 |
| Bos taurus |
Calf thymus DNA |
Log K |
5.57 |
None |
10.1021/jm00392a009 |
| Bos taurus |
Calf thymus DNA |
Log K |
5.65 |
None |
10.1021/jm00387a012 |
| Bos taurus |
Calf thymus DNA |
Q |
3.8 |
uM |
10.1021/jm00018a009 |
| Bos taurus |
Calf thymus DNA |
Ratio |
0.3 |
None |
10.1016/j.bmc.2010.04.074 |
| Bos taurus |
Calf thymus DNA |
Ratio |
0.3 |
None |
10.1016/j.ejmech.2010.08.061 |
| Bos taurus |
Calf thymus DNA |
Tm shift |
1.0 |
degrees C |
10.1021/jm00018a009 |
| Cricetulus griseus |
CHO-AA8 |
IC50 |
0.6 |
nM |
10.1021/jm00121a007 |
| Cricetulus griseus |
DC3F |
IC50 |
4.0 |
nM |
10.1021/jm00017a006 |
| Cricetulus griseus |
DC3F/AD-II |
IC50 |
47.0 |
nM |
10.1021/jm00017a006 |
| Cricetulus griseus |
V79 |
IC50 |
5800.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Cricetulus griseus |
XRS6 |
IC50 |
240.0 |
nM |
10.1021/jm00022a016 |
| Homo sapiens |
2008 |
IC50 |
4310.0 |
nM |
10.1016/j.bmc.2008.11.072 |
| Homo sapiens |
786-0 |
GI50 |
149.62 |
nM |
None |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
58478.9 |
nM |
None |
| Homo sapiens |
A2780 |
GI50 |
27.0 |
nM |
10.1021/acsmedchemlett.9b00557 |
| Homo sapiens |
A2780 |
IC50 |
100.0 |
nM |
10.1021/jm00018a009 |
| Homo sapiens |
A2780 |
IC50 |
350.0 |
nM |
10.1016/s0960-894x(97)10207-4 |
| Homo sapiens |
A-431 |
IC50 |
170.0 |
nM |
10.1016/j.bmc.2010.12.037 |
| Homo sapiens |
A-431 |
IC50 |
5890.0 |
nM |
10.1016/j.bmc.2008.11.072 |
| Homo sapiens |
A498 |
GI50 |
291.74 |
nM |
None |
| Homo sapiens |
A549 |
Activity |
2.8 |
% |
10.1039/c9md00597h |
| Homo sapiens |
A549 |
Activity |
16.1 |
% |
10.1039/c9md00597h |
| Homo sapiens |
A549 |
Activity |
nan |
None |
10.1039/c9md00597h |
| Homo sapiens |
A549 |
GI50 |
48.98 |
nM |
None |
| Homo sapiens |
A549 |
IC50 |
30.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
A549 |
IC50 |
3520.0 |
nM |
10.1016/j.bmc.2008.11.072 |
| Homo sapiens |
A549 |
IC50 |
5960.0 |
nM |
10.1016/j.ejmech.2016.03.066 |
| Homo sapiens |
A549 |
IC50 |
22200.0 |
nM |
10.1039/c9md00597h |
| Homo sapiens |
A549 |
IC50 |
nan |
None |
10.1016/j.bmc.2017.04.030 |
| Homo sapiens |
ACHN |
GI50 |
52.48 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aldehyde oxidase |
IC50 |
3200.0 |
nM |
10.1021/jm100888d |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
1300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
2800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
44668.4 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
354.8 |
nM |
None |
| Homo sapiens |
Ataxin-2 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
14575.0 |
nM |
None |
| Homo sapiens |
ATPase family AAA domain-containing protein 5 |
Potency |
20587.8 |
nM |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
8900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
BT-549 |
GI50 |
1037.53 |
nM |
None |
| Homo sapiens |
CAKI-1 |
GI50 |
97.27 |
nM |
None |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Caspase-1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Caspase-7 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
CCRF-CEM |
Activity |
68.0 |
% |
10.1016/j.bmc.2008.02.063 |
| Homo sapiens |
CCRF-CEM |
GI50 |
56.1 |
nM |
None |
| Homo sapiens |
CCRF-CEM |
IC50 |
30.0 |
nM |
10.1016/j.bmcl.2019.126714 |
| Homo sapiens |
CCRF-CEM |
IC50 |
130.0 |
nM |
10.1016/j.bmc.2008.02.063 |
| Homo sapiens |
CCRF-CEM |
IC50 |
139.0 |
nM |
10.1021/jm00017a006 |
| Homo sapiens |
CCRF-CEM |
IC50 |
180.0 |
nM |
10.1016/j.ejmech.2016.03.066 |
| Homo sapiens |
CCRF-CEM |
IC50 |
130000.0 |
nM |
10.1021/jm030253d |
| Homo sapiens |
CCRF-CEM |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
1000.0 |
nM |
None |
| Homo sapiens |
Cellular tumor antigen p53 |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
CEM-VLB |
IC50 |
520.0 |
nM |
10.1021/jm00017a006 |
| Homo sapiens |
CEM-VM1 |
IC50 |
1910.0 |
nM |
10.1021/jm00017a006 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Chromobox protein homolog 1 |
Potency |
79432.8 |
nM |
None |
| Homo sapiens |
COLO 205 |
GI50 |
2857.59 |
nM |
None |
| Homo sapiens |
COLO 205 |
IC50 |
1100.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
2900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
7943.28 |
nM |
None |
| Homo sapiens |
Cytochrome P450 1A2 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2C9 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
10200.0 |
nM |
10.1021/jm049934e |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
10500.0 |
nM |
10.1021/jm049934e |
| Homo sapiens |
Cytochrome P450 2D6 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 2D6 |
Ki |
7500.0 |
nM |
10.1021/jm049934e |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
19952.62 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
Inhibition |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
Cytochrome P450 3A4 |
Potency |
19952.6 |
nM |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DLD-1 |
GI50 |
2786.12 |
nM |
None |
| Homo sapiens |
DLD-1 |
IC50 |
80.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| Homo sapiens |
DLD-1 |
IC50 |
570.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| Homo sapiens |
DMS-114 |
GI50 |
184.5 |
nM |
None |
| Homo sapiens |
DMS-273 |
GI50 |
65.92 |
nM |
None |
| Homo sapiens |
DNA |
Activity |
nan |
None |
10.1039/c9md00597h |
| Homo sapiens |
DNA topoisomerase I |
Activity |
nan |
None |
10.1016/j.ejmech.2016.09.019 |
| Homo sapiens |
DNA topoisomerase I |
Activity |
nan |
None |
10.1016/j.ejmech.2017.11.011 |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1016/j.ejmech.2013.08.040 |
| Homo sapiens |
DNA topoisomerase I |
Inhibition |
nan |
% |
10.1016/j.ejmech.2021.113817 |
| Homo sapiens |
DNA topoisomerase II |
Activity |
nan |
None |
10.1021/jm00137a004 |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1016/0960-894X(95)00043-S |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1016/0960-894X(95)00044-T |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1016/0960-894X(95)00160-U |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1016/0960-894X(96)00230-2 |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1016/S0960-894X(00)80048-7 |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1021/jm00071a010 |
| Homo sapiens |
DNA topoisomerase II |
EC50 |
720.0 |
nM |
10.1021/jm9708083 |
| Homo sapiens |
DNA topoisomerase II |
IC50 |
1000.0 |
nM |
10.1021/jm00017a006 |
| Homo sapiens |
DNA topoisomerase II |
IC90 |
33000.0 |
nM |
10.1021/jm00022a016 |
| Homo sapiens |
DNA topoisomerase II |
IC90 |
33000.0 |
nM |
10.1021/jm00048a017 |
| Homo sapiens |
DNA topoisomerase II |
Uncut DNA |
1.0 |
% |
10.1016/s0960-894x(97)10207-4 |
| Homo sapiens |
DNA topoisomerase II |
Uncut DNA |
4.0 |
% |
10.1016/s0960-894x(97)10207-4 |
| Homo sapiens |
DNA topoisomerase II |
Uncut DNA |
12.0 |
% |
10.1016/s0960-894x(97)10207-4 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
8.5 |
uM |
10.1016/j.bmcl.2016.12.011 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1016/j.bmcl.2007.09.042 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1016/j.bmcl.2016.09.031 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1016/j.bmcl.2016.12.011 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1016/j.ejmech.2008.12.011 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1016/j.ejmech.2015.01.038 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1016/j.ejmech.2019.01.015 |
| Homo sapiens |
DNA topoisomerase II alpha |
Activity |
nan |
None |
10.1021/jm900627v |
| Homo sapiens |
DNA topoisomerase II alpha |
IC50 |
9940.0 |
nM |
10.1016/j.bmc.2009.03.052 |
| Homo sapiens |
DNA topoisomerase II alpha |
IC50 |
16000.0 |
nM |
10.1039/c9md00597h |
| Homo sapiens |
DNA topoisomerase II alpha |
INH |
0.05 |
mM |
10.1016/j.bmcl.2012.08.032 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.bmc.2012.03.071 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.bmc.2018.06.016 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.bmcl.2016.09.031 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.bmcl.2016.12.011 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.05.023 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.ejmech.2018.06.004 |
| Homo sapiens |
DNA topoisomerase II alpha |
Inhibition |
nan |
% |
10.1016/j.ejmech.2019.111592 |
| Homo sapiens |
DNA topoisomerase II beta |
EC50 |
11000.0 |
nM |
10.1016/0960-894X(95)00044-T |
| Homo sapiens |
DNA topoisomerase II beta |
IC50 |
2760.0 |
nM |
10.1016/j.ejmech.2018.03.026 |
| Homo sapiens |
DNA topoisomerase II beta |
Unwinding |
nan |
None |
10.1021/jm00126a025 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
163.6 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
Potency |
1122.0 |
nM |
None |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
6900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
DU-145 |
GI50 |
65.46 |
nM |
None |
| Homo sapiens |
DU-145 |
IC50 |
300.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
EKVX |
GI50 |
2079.7 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
31622.8 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
29000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Flap endonuclease 1 |
Potency |
5972.8 |
nM |
None |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HCC1937 |
IC50 |
7850.0 |
nM |
10.1016/j.ejmech.2017.07.050 |
| Homo sapiens |
HCC 2998 |
GI50 |
1244.51 |
nM |
None |
| Homo sapiens |
HCT-116 |
GI50 |
954.99 |
nM |
None |
| Homo sapiens |
HCT-116 |
IC50 |
700.0 |
nM |
10.1016/j.bmcl.2007.02.065 |
| Homo sapiens |
HCT-116 |
IC50 |
1000.0 |
nM |
10.1016/j.bmc.2018.06.016 |
| Homo sapiens |
HCT-116 |
IC50 |
3890.0 |
nM |
10.1016/j.ejmech.2017.07.050 |
| Homo sapiens |
HCT-116 |
IC50 |
6300.0 |
nM |
10.1021/jm00022a016 |
| Homo sapiens |
HCT-116 |
IC50 |
6300.0 |
nM |
10.1021/jm00048a017 |
| Homo sapiens |
HCT-15 |
GI50 |
716.14 |
nM |
None |
| Homo sapiens |
HCT-15 |
IC50 |
300.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
HCT-8 |
IC50 |
120.0 |
nM |
10.1021/jm00159a035 |
| Homo sapiens |
HCT-8 |
IC50 |
120.0 |
nM |
10.1021/jm00387a012 |
| Homo sapiens |
HCT-8 |
IC50 |
300.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
HEK293 |
Potency |
580.2 |
nM |
None |
| Homo sapiens |
HeLa |
GI50 |
31.0 |
nM |
10.1021/acsmedchemlett.9b00557 |
| Homo sapiens |
HeLa |
IC50 |
12.0 |
nM |
10.1016/j.bmc.2007.11.063 |
| Homo sapiens |
HeLa |
IC50 |
12.0 |
nM |
10.1016/j.bmc.2010.12.037 |
| Homo sapiens |
HeLa |
IC50 |
340.0 |
nM |
10.1016/j.ejmech.2016.03.066 |
| Homo sapiens |
HeLa |
IC50 |
9500.0 |
nM |
10.1016/j.bmc.2007.10.084 |
| Homo sapiens |
HeLa |
IC50 |
9500.0 |
nM |
10.1016/j.bmc.2009.03.052 |
| Homo sapiens |
HeLa |
IC50 |
19190.0 |
nM |
10.1016/j.bmc.2017.04.030 |
| Homo sapiens |
HepG2 |
IC50 |
5210.0 |
nM |
10.1016/j.bmc.2017.04.030 |
| Homo sapiens |
HepG2 |
IC50 relative |
2700.0 |
nM |
10.6019/EOS300108 |
| Homo sapiens |
HERG |
AC50 |
970.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
IC50 |
208.93 |
nM |
10.1016/j.ejmech.2010.11.042 |
| Homo sapiens |
HERG |
IC50 |
210.0 |
nM |
10.1016/j.bmc.2008.01.017 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
9499.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
IC50 |
379700000.0 |
nM |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
76.6 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
96.64 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
nan |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
11917.3 |
nM |
None |
| Homo sapiens |
HL-60 |
GI50 |
51.88 |
nM |
None |
| Homo sapiens |
HL-60 |
IC50 |
5.1 |
nM |
10.1016/j.bmc.2007.11.063 |
| Homo sapiens |
HL-60 |
IC50 |
6.0 |
nM |
10.1016/j.bmc.2010.12.037 |
| Homo sapiens |
HL-60 |
IC50 |
21.0 |
nM |
10.1021/jm00017a006 |
| Homo sapiens |
HL-60 |
IC50 |
80.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
HL-60 |
IC50 |
400.0 |
nM |
10.1016/s0960-894x(97)10207-4 |
| Homo sapiens |
HL-60 |
IC50 |
1150.0 |
nM |
10.1016/j.bmc.2008.11.072 |
| Homo sapiens |
HOP-18 |
GI50 |
699.84 |
nM |
None |
| Homo sapiens |
HOP-62 |
GI50 |
83.95 |
nM |
None |
| Homo sapiens |
HOP-92 |
GI50 |
523.6 |
nM |
None |
| Homo sapiens |
Hs-578T |
GI50 |
1794.73 |
nM |
None |
| Homo sapiens |
Hs-578T |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
HT-1080 |
GI50 |
1600.0 |
nM |
10.1016/j.ejmech.2008.02.017 |
| Homo sapiens |
HT-1080 |
GI50 |
1600.0 |
nM |
10.1016/j.ejmech.2012.03.011 |
| Homo sapiens |
HT-29 |
Activity |
nan |
None |
10.1021/np50063a010 |
| Homo sapiens |
HT-29 |
GI50 |
1770.11 |
nM |
None |
| Homo sapiens |
HT-29 |
GI50 |
16800.0 |
nM |
10.1016/j.ejmech.2008.02.017 |
| Homo sapiens |
HT-29 |
GI50 |
16800.0 |
nM |
10.1016/j.ejmech.2012.03.011 |
| Homo sapiens |
HT-29 |
IC50 |
559.0 |
nM |
10.1021/np50063a010 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
5011.9 |
nM |
None |
| Homo sapiens |
IGROV-1 |
GI50 |
2404.36 |
nM |
None |
| Homo sapiens |
Jurkat |
IC50 |
20.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| Homo sapiens |
Jurkat |
IC50 |
37.0 |
nM |
10.1021/jm010041l |
| Homo sapiens |
Jurkat |
IC50 |
37.0 |
nM |
10.1021/jm970004n |
| Homo sapiens |
Jurkat |
IC50 |
37.0 |
nM |
10.1021/jm980687m |
| Homo sapiens |
Jurkat |
IC50 |
80.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| Homo sapiens |
Jurkat |
IC50 |
200.0 |
nM |
10.1021/jm970232h |
| Homo sapiens |
Jurkat |
IC50 |
1000.0 |
nM |
10.1021/jm00036a014 |
| Homo sapiens |
Jurkat |
IC50 ratio |
74.0 |
None |
10.1021/jm010041l |
| Homo sapiens |
Jurkat |
IC50 ratio |
85.0 |
None |
10.1021/jm010041l |
| Homo sapiens |
Jurkat |
Ratio |
73.7 |
None |
10.1021/jm970004n |
| Homo sapiens |
Jurkat |
Ratio |
74.0 |
None |
10.1021/jm980687m |
| Homo sapiens |
Jurkat |
Ratio |
84.9 |
None |
10.1021/jm970004n |
| Homo sapiens |
Jurkat |
Ratio |
85.0 |
None |
10.1021/jm980687m |
| Homo sapiens |
Jurkat |
TI |
1.5 |
None |
10.1021/jm00036a014 |
| Homo sapiens |
K562 |
GI50 |
901.57 |
nM |
None |
| Homo sapiens |
K562 |
IC50 |
23.0 |
nM |
10.1021/np070332i |
| Homo sapiens |
K562 |
IC50 |
710.0 |
nM |
10.1016/j.bmcl.2019.126714 |
| Homo sapiens |
K562 |
IC50 |
880.0 |
nM |
10.1016/j.bmc.2017.04.030 |
| Homo sapiens |
K562 |
IC50 |
13800.0 |
nM |
10.1039/c9md00597h |
| Homo sapiens |
K562 |
IC50 |
19900.0 |
nM |
10.1016/j.bmc.2007.10.084 |
| Homo sapiens |
K562 |
IC50 |
19900.0 |
nM |
10.1016/j.bmc.2009.03.052 |
| Homo sapiens |
K562 |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
7000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
KM12 |
GI50 |
1435.49 |
nM |
None |
| Homo sapiens |
KM-20L2 |
GI50 |
1452.11 |
nM |
None |
| Homo sapiens |
Liver microsomes |
Activity |
nan |
None |
10.1021/tx300075j |
| Homo sapiens |
Liver microsomes |
Stability |
nan |
% |
10.1021/tx300075j |
| Homo sapiens |
LOX IMVI |
GI50 |
178.65 |
nM |
None |
| Homo sapiens |
LXFL 529 |
GI50 |
3318.94 |
nM |
None |
| Homo sapiens |
M14 |
GI50 |
266.07 |
nM |
None |
| Homo sapiens |
M19-MEL |
GI50 |
1887.99 |
nM |
None |
| Homo sapiens |
M21 |
GI50 |
49600.0 |
nM |
10.1016/j.ejmech.2008.02.017 |
| Homo sapiens |
M21 |
GI50 |
49600.0 |
nM |
10.1016/j.ejmech.2012.03.011 |
| Homo sapiens |
Malme-3M |
GI50 |
610.94 |
nM |
None |
| Homo sapiens |
MCF7 |
GI50 |
103.28 |
nM |
None |
| Homo sapiens |
MCF7 |
GI50 |
5600.0 |
nM |
10.1016/j.ejmech.2008.02.017 |
| Homo sapiens |
MCF7 |
GI50 |
5600.0 |
nM |
10.1016/j.ejmech.2012.03.011 |
| Homo sapiens |
MCF7 |
IC50 |
75.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
MCF7 |
IC50 |
910.0 |
nM |
10.1016/j.ejmech.2019.111592 |
| Homo sapiens |
MCF7 |
IC50 |
5130.0 |
nM |
10.1016/j.bmc.2008.11.072 |
| Homo sapiens |
MCF7 |
IC50 |
8700.0 |
nM |
10.1016/j.ejmech.2017.07.050 |
| Homo sapiens |
MCF7 |
IC50 |
21700.0 |
nM |
10.1016/j.bmc.2007.11.051 |
| Homo sapiens |
MCF7 |
IC50 |
21700.0 |
nM |
10.1016/j.bmcl.2007.02.065 |
| Homo sapiens |
MCF7 |
IC50 |
26760.0 |
nM |
10.1016/j.ejmech.2016.03.066 |
| Homo sapiens |
MDA-MB-231 |
GI50 |
2409.91 |
nM |
None |
| Homo sapiens |
MDA-MB-231 |
IC50 |
140.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
10050.0 |
nM |
10.1016/j.bmc.2018.06.016 |
| Homo sapiens |
MDA-MB-231 |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
MDA-MB-435 |
GI50 |
4539.42 |
nM |
None |
| Homo sapiens |
MDA-MB-435 |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
MDA-MB-468 |
IC50 |
490.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
MDA-MB-468 |
IC50 |
8500.0 |
nM |
10.1016/j.bmcl.2007.02.065 |
| Homo sapiens |
MDA-N |
GI50 |
3318.94 |
nM |
None |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MOLT-4 |
GI50 |
33.19 |
nM |
None |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MRC5 |
IC50 |
15400.0 |
nM |
10.1039/c9md00597h |
| Homo sapiens |
MSTO-211H |
GI50 |
19.0 |
nM |
10.1021/acsmedchemlett.9b00557 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
7430.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
7900.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
8600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MX1 |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
NCI/ADR-RES |
GI50 |
3419.79 |
nM |
None |
| Homo sapiens |
NCI/ADR-RES |
IC50 |
1165.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
NCI-H226 |
GI50 |
124.74 |
nM |
None |
| Homo sapiens |
NCI-H226 |
IC50 |
1010.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
NCI-H23 |
GI50 |
152.41 |
nM |
None |
| Homo sapiens |
NCI-H322M |
GI50 |
3775.72 |
nM |
None |
| Homo sapiens |
NCI-H322M |
IC50 |
210.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
NCI-H358 |
IC50 |
150.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
NCI-H460 |
GI50 |
27.99 |
nM |
None |
| Homo sapiens |
NCI-H460 |
IC50 |
60.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
NCI-H460 |
IC50 |
200.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
NCI-H522 |
GI50 |
668.34 |
nM |
None |
| Homo sapiens |
NCI-H647 |
IC50 |
70.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
9299.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
11582.1 |
nM |
None |
| Homo sapiens |
OVCAR-3 |
Activity |
1.8 |
% |
10.1016/j.ejmech.2007.04.008 |
| Homo sapiens |
OVCAR-3 |
Activity |
12.7 |
% |
10.1016/j.ejmech.2007.04.008 |
| Homo sapiens |
OVCAR-3 |
Activity |
41.3 |
% |
10.1016/j.ejmech.2007.04.008 |
| Homo sapiens |
OVCAR-3 |
Activity |
44.7 |
% |
10.1016/j.ejmech.2007.04.008 |
| Homo sapiens |
OVCAR-3 |
GI50 |
2673.01 |
nM |
None |
| Homo sapiens |
OVCAR-4 |
GI50 |
4045.76 |
nM |
None |
| Homo sapiens |
OVCAR-5 |
GI50 |
1581.25 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
GI50 |
571.48 |
nM |
None |
| Homo sapiens |
OVCAR-8 |
IC50 |
1400.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
PBMC |
IC50 |
21700.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
PC-3 |
GI50 |
414.95 |
nM |
None |
| Homo sapiens |
PC-3 |
IC50 |
3300.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
P-glycoprotein 1 |
Activity |
nan |
None |
10.1016/j.bbrc.2004.01.156 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
6200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ras-related protein Rab-9A |
Potency |
73078.0 |
nM |
None |
| Homo sapiens |
Regulator of G-protein signaling 4 |
Potency |
37685.8 |
nM |
None |
| Homo sapiens |
RPMI-8226 |
GI50 |
351.56 |
nM |
None |
| Homo sapiens |
RXF 393 |
GI50 |
1552.39 |
nM |
None |
| Homo sapiens |
RXF 631 |
GI50 |
509.33 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
130.9 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
521.2 |
nM |
None |
| Homo sapiens |
Serine/threonine-protein kinase mTOR |
Potency |
3689.8 |
nM |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
8000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
SF-268 |
GI50 |
414.95 |
nM |
None |
| Homo sapiens |
SF-295 |
GI50 |
104.47 |
nM |
None |
| Homo sapiens |
SF-295 |
IC50 |
500.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
SF-539 |
GI50 |
207.49 |
nM |
None |
| Homo sapiens |
SH-SY5Y |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Signal transducer and activator of transcription 6 |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
SK-BR-3 |
IC50 |
60.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
SK-MEL-2 |
GI50 |
3698.28 |
nM |
None |
| Homo sapiens |
SK-MEL-28 |
GI50 |
2588.21 |
nM |
None |
| Homo sapiens |
SK-MEL-5 |
GI50 |
319.15 |
nM |
None |
| Homo sapiens |
SK-OV-3 |
GI50 |
398.11 |
nM |
None |
| Homo sapiens |
SN12C |
GI50 |
130.92 |
nM |
None |
| Homo sapiens |
SN12K1 |
GI50 |
106.41 |
nM |
None |
| Homo sapiens |
SNB-19 |
GI50 |
295.8 |
nM |
None |
| Homo sapiens |
SNB-75 |
GI50 |
402.72 |
nM |
None |
| Homo sapiens |
SNB-78 |
GI50 |
3971.92 |
nM |
None |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
5000.0 |
nM |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
68.4 |
% |
10.1021/jm8003152 |
| Homo sapiens |
SR |
GI50 |
38.28 |
nM |
None |
| Homo sapiens |
SW480 |
IC50 |
27700.0 |
nM |
10.1016/j.bmc.2007.10.084 |
| Homo sapiens |
SW480 |
IC50 |
27700.0 |
nM |
10.1016/j.bmc.2009.03.052 |
| Homo sapiens |
SW-620 |
GI50 |
561.05 |
nM |
None |
| Homo sapiens |
SW-620 |
IC50 |
300.0 |
nM |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
SW-620 |
IC50 |
16700.0 |
nM |
10.1016/j.bmc.2007.10.084 |
| Homo sapiens |
SW-620 |
IC50 |
16700.0 |
nM |
10.1016/j.bmc.2009.03.052 |
| Homo sapiens |
T47D |
GI50 |
440.55 |
nM |
None |
| Homo sapiens |
T47D |
IC50 |
220.0 |
nM |
10.1021/jm9909490 |
| Homo sapiens |
T47D |
IC50 |
940.0 |
nM |
10.1016/j.ejmech.2019.111592 |
| Homo sapiens |
Thrombopoietin |
Potency |
2511.9 |
nM |
None |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
12000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
TK-10 |
GI50 |
2630.27 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
U-251 |
GI50 |
165.96 |
nM |
None |
| Homo sapiens |
U-937 |
IC50 |
80.0 |
nM |
10.1016/j.bmcl.2019.126714 |
| Homo sapiens |
U-937 |
IC50 |
610.0 |
nM |
10.1016/j.bmc.2017.04.030 |
| Homo sapiens |
U-937 |
IC50 |
610.0 |
nM |
10.1016/j.bmc.2018.06.016 |
| Homo sapiens |
UACC-257 |
GI50 |
2951.21 |
nM |
None |
| Homo sapiens |
UACC-62 |
GI50 |
285.1 |
nM |
None |
| Homo sapiens |
UACC-62 |
IC50 |
nan |
None |
10.1016/j.bmc.2012.04.007 |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
562.3 |
nM |
None |
| Homo sapiens |
UO-31 |
GI50 |
660.69 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
XF498 |
GI50 |
753.36 |
nM |
None |
| Homo sapiens |
ZR-75-1 |
IC50 |
180.0 |
nM |
10.1021/jm9909490 |
| Leishmania major |
Leishmania major |
IC50 |
1500.0 |
nM |
10.1021/jm970232h |
| Leishmania major |
Leishmania major |
Therapeutic index |
0.1 |
None |
10.1021/jm970232h |
| Mus musculus |
J774 |
IC50 |
900.6 |
nM |
10.1016/0960-894X(95)00300-I |
| Mus musculus |
J774.2 |
IC50 |
1353.9 |
nM |
10.1016/0960-894X(95)00300-I |
| Mus musculus |
J774.2 |
IC50 |
1485.2 |
nM |
10.1016/0960-894X(95)00300-I |
| Mus musculus |
L1210 |
Activity |
6.7 |
mg/kg/day |
10.1021/jm00199a002 |
| Mus musculus |
L1210 |
Activity |
12.0 |
mg/kg/day |
10.1021/jm00228a007 |
| Mus musculus |
L1210 |
GI |
6.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
8.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
29.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
42.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
50.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
57.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
75.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
82.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
87.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
GI |
92.0 |
% |
10.1021/jm00230a002 |
| Mus musculus |
L1210 |
IC50 |
33.0 |
nM |
10.1021/jm00159a035 |
| Mus musculus |
L1210 |
IC50 |
33.0 |
nM |
10.1021/jm00387a012 |
| Mus musculus |
L1210 |
IC50 |
50.0 |
nM |
10.1021/jm00018a009 |
| Mus musculus |
L1210 |
ID50 |
35.0 |
nM |
10.1021/jm00352a027 |
| Mus musculus |
L1210 |
ID50 |
35.0 |
nM |
10.1021/jm00365a013 |
| Mus musculus |
L1210 |
ID50 |
35.0 |
nM |
10.1021/jm00365a014 |
| Mus musculus |
L1210 |
ID50 |
35.0 |
nM |
10.1021/jm00369a021 |
| Mus musculus |
L1210 |
ID50 |
35.0 |
nM |
10.1021/jm00369a022 |
| Mus musculus |
L1210 |
ID50 |
35.0 |
nM |
10.1021/jm00374a020 |
| Mus musculus |
L1210 |
ILS |
27.0 |
% |
10.1021/jm00214a012 |
| Mus musculus |
L1210 |
ILS |
27.0 |
% |
10.1021/jm00218a001 |
| Mus musculus |
L1210 |
ILS |
114.0 |
% |
10.1021/jm00205a013 |
| Mus musculus |
L1210 |
ILS |
114.0 |
% |
10.1021/jm00214a012 |
| Mus musculus |
L1210 |
ILS |
114.0 |
% |
10.1021/jm00218a001 |
| Mus musculus |
L1210 |
ILSmax |
111.0 |
% |
10.1021/jm00350a004 |
| Mus musculus |
L1210 |
ILSmax |
114.0 |
% |
10.1021/jm00199a002 |
| Mus musculus |
L1210 |
Log 1/D50 |
5.09 |
None |
10.1021/jm00345a015 |
| Mus musculus |
L1210 |
OD |
6.7 |
mg kg-1 |
10.1021/jm00369a022 |
| Mus musculus |
L1210 |
T/C |
196.0 |
% |
10.1021/jm00228a007 |
| Mus musculus |
L5178Y |
Induced frequency |
439.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Induced frequency |
733.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Mean value |
53.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Mean value |
57.7 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Mutation frequency |
577.0 |
10e6 F |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Mutation frequency |
862.0 |
10e6 F |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Relative activity |
10.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Relative activity |
67.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Relative toxicity |
62.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Viability |
12.3 |
None |
10.1021/jm00166a022 |
| Mus musculus |
L5178Y |
Viability |
20.0 |
None |
10.1021/jm00166a022 |
| Mus musculus |
Lewis lung carcinoma cell line |
D50 |
nan |
None |
10.1021/jm00159a035 |
| Mus musculus |
Lewis lung carcinoma cell line |
IC50 |
12.0 |
nM |
10.1021/jm010041l |
| Mus musculus |
Lewis lung carcinoma cell line |
IC50 |
12.0 |
nM |
10.1021/jm980687m |
| Mus musculus |
Lewis lung carcinoma cell line |
ILSmax |
42.0 |
% |
10.1021/jm00159a035 |
| Mus musculus |
Lewis lung carcinoma cell line |
ILSmax |
42.0 |
% |
10.1021/jm00387a012 |
| Mus musculus |
Lewis lung carcinoma cell line |
OD |
13.3 |
mg kg-1 |
10.1021/jm00159a035 |
| Mus musculus |
LLTC cell line |
IC50 |
12.0 |
nM |
10.1021/jm970004n |
| Mus musculus |
Mus musculus |
Activity |
6.7 |
mg kg-1 |
10.1021/jm00214a012 |
| Mus musculus |
Mus musculus |
Activity |
6.7 |
mg kg-1 |
10.1021/jm00218a001 |
| Mus musculus |
Mus musculus |
Activity |
6.7 |
mg/kg/day |
10.1021/jm00205a013 |
| Mus musculus |
Mus musculus |
Average survival |
7.6 |
day |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average survival |
12.2 |
day |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average survival |
14.1 |
day |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
-4.3 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
-3.8 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
-3.2 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
-2.1 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
-1.4 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
-0.7 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
0.1 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
22.7 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
22.8 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Average weight change |
24.5 |
g |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
AWC |
-2.1 |
g |
10.1021/jm00017a006 |
| Mus musculus |
Mus musculus |
AWC |
-1.4 |
g |
10.1021/jm00017a006 |
| Mus musculus |
Mus musculus |
AWC |
0.2 |
g |
10.1021/jm00017a006 |
| Mus musculus |
Mus musculus |
Cures |
0.0 |
None |
10.1021/jm020420u |
| Mus musculus |
Mus musculus |
Growth delay |
2.0 |
day |
10.1021/jm020420u |
| Mus musculus |
Mus musculus |
ILS |
78.0 |
% |
10.1021/jm00164a054 |
| Mus musculus |
Mus musculus |
ILS |
114.0 |
% |
10.1021/jm00369a022 |
| Mus musculus |
Mus musculus |
ILS max |
nan |
None |
10.1021/jm00392a009 |
| Mus musculus |
Mus musculus |
Increase in life-span |
19.0 |
% |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Increase in life-span |
91.0 |
% |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Increase in life-span |
120.0 |
% |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
LCK |
1.8 |
None |
10.1016/0960-894X(96)00230-2 |
| Mus musculus |
Mus musculus |
LCK |
1.8 |
None |
10.1021/jm9708083 |
| Mus musculus |
Mus musculus |
LD10 |
9.0 |
mg kg-1 day-1 |
10.1021/jm00177a011 |
| Mus musculus |
Mus musculus |
LD10 |
9.0 |
None |
10.1021/jm00137a009 |
| Mus musculus |
Mus musculus |
Log 1/D40 |
5.24 |
None |
10.1021/jm00177a011 |
| Mus musculus |
Mus musculus |
Log 1/D40 |
5.29 |
None |
10.1021/jm00137a009 |
| Mus musculus |
Mus musculus |
Log ILS max |
2.06 |
None |
10.1021/jm00177a011 |
| Mus musculus |
Mus musculus |
LTC |
0.0 |
None |
10.1016/0960-894X(96)00230-2 |
| Mus musculus |
Mus musculus |
LTC |
0.0 |
None |
10.1021/jm9708083 |
| Mus musculus |
Mus musculus |
MTD |
48.0 |
mg kg-1 |
10.1016/0960-894X(95)00044-T |
| Mus musculus |
Mus musculus |
MTD |
48.0 |
mg kg-1 |
10.1016/0960-894X(95)00160-U |
| Mus musculus |
Mus musculus |
MTD |
48.0 |
mg kg-1 |
10.1016/0960-894X(96)00230-2 |
| Mus musculus |
Mus musculus |
MTD |
48.0 |
mg kg-1 |
10.1021/jm9708083 |
| Mus musculus |
Mus musculus |
T1/2 |
1.767 |
hr |
10.1021/jm00218a001 |
| Mus musculus |
Mus musculus |
T/C |
0.0 |
% |
10.1016/0960-894X(95)00044-T |
| Mus musculus |
Mus musculus |
T/C |
0.0 |
% |
10.1016/0960-894X(95)00160-U |
| Mus musculus |
Mus musculus |
T/C |
0.0 |
% |
10.1016/0960-894X(96)00230-2 |
| Mus musculus |
Mus musculus |
T/C |
0.0 |
% |
10.1021/jm9708083 |
| Mus musculus |
Mus musculus |
T/C |
0.24 |
None |
10.1021/jm00017a006 |
| Mus musculus |
Mus musculus |
T/C |
0.31 |
None |
10.1021/jm00017a006 |
| Mus musculus |
Mus musculus |
T/C |
0.46 |
None |
10.1021/jm00017a006 |
| Mus musculus |
Mus musculus |
Toxicity related death |
0.0 |
None |
10.1021/jm9901226 |
| Mus musculus |
Mus musculus |
Toxicity related death |
nan |
None |
10.1021/jm9901226 |
| Mus musculus |
P388 |
Activity |
58.0 |
% |
10.1021/jm00374a020 |
| Mus musculus |
P388 |
Activity |
nan |
None |
10.1021/np50063a010 |
| Mus musculus |
P388 |
D50 |
3.0 |
mg kg-1 |
10.1021/jm00159a035 |
| Mus musculus |
P388 |
D50 |
3.0 |
mg kg-1 day-1 |
10.1021/jm00374a020 |
| Mus musculus |
P388 |
D50 |
3.0 |
mg kg-1 day-1 |
10.1021/jm00387a012 |
| Mus musculus |
P388 |
GI50 |
31.77 |
nM |
None |
| Mus musculus |
P388 |
IC50 |
12.0 |
nM |
10.1021/jm00164a054 |
| Mus musculus |
P388 |
IC50 |
20.0 |
nM |
10.1021/jm010041l |
| Mus musculus |
P388 |
IC50 |
20.0 |
nM |
10.1021/jm970004n |
| Mus musculus |
P388 |
IC50 |
20.0 |
nM |
10.1021/jm980687m |
| Mus musculus |
P388 |
IC50 |
150.0 |
nM |
10.1016/0960-894X(95)00044-T |
| Mus musculus |
P388 |
IC50 |
150.0 |
nM |
10.1016/0960-894X(95)00160-U |
| Mus musculus |
P388 |
IC50 |
150.0 |
nM |
10.1016/0960-894X(96)00230-2 |
| Mus musculus |
P388 |
IC50 |
150.0 |
nM |
10.1021/jm9708083 |
| Mus musculus |
P388 |
IC50 |
229.0 |
nM |
10.1021/np50063a010 |
| Mus musculus |
P388 |
IC50 |
890.0 |
nM |
10.1021/jm00164a054 |
| Mus musculus |
P388 |
ID50 |
30.0 |
nM |
10.1021/jm00352a027 |
| Mus musculus |
P388 |
ILS |
63.0 |
% |
10.1021/jm00369a021 |
| Mus musculus |
P388 |
ILS |
78.0 |
% |
10.1021/jm00352a027 |
| Mus musculus |
P388 |
ILS |
78.0 |
% |
10.1021/jm00365a013 |
| Mus musculus |
P388 |
ILS |
78.0 |
% |
10.1021/jm00369a021 |
| Mus musculus |
P388 |
ILS |
111.0 |
% |
10.1021/jm00365a014 |
| Mus musculus |
P388 |
ILS max |
78.0 |
None |
10.1021/jm00392a009 |
| Mus musculus |
P388 |
ILSmax |
78.0 |
% |
10.1021/jm00159a035 |
| Mus musculus |
P388 |
ILSmax |
78.0 |
% |
10.1021/jm00387a012 |
| Mus musculus |
P388 |
IZ |
10.0 |
mm |
10.1021/np50063a010 |
| Mus musculus |
P388 |
IZ |
20.0 |
mm |
10.1021/np50063a010 |
| Mus musculus |
P388 |
OD |
13.3 |
mg kg-1 |
10.1021/jm00159a035 |
| Mus musculus |
P388 |
OD |
13.3 |
mg kg-1 |
10.1021/jm00365a013 |
| Mus musculus |
P388 |
OD |
13.3 |
mg kg-1 day-1 |
10.1021/jm00374a020 |
| Mus musculus |
P388 |
OD |
13.3 |
None |
10.1021/jm00392a009 |
| Mus musculus |
P388 |
Ratio |
0.74 |
None |
10.1021/jm00164a054 |
| Mus musculus |
P388 |
T/C |
174.0 |
% |
10.1021/jm00126a025 |
| Mus musculus |
P388 |
T/C |
198.0 |
% |
10.1021/jm00126a025 |
| Mus musculus |
P388 |
T/C |
223.0 |
% |
10.1021/jm00126a025 |
| Mus musculus |
P388/ADR |
GI50 |
264.85 |
nM |
None |
| Mus musculus |
P388/ADR |
OD |
13.3 |
None |
10.1021/jm00392a009 |
| Mus musculus |
RAW264.7 |
CC50 |
95500.0 |
nM |
10.1016/j.ejmech.2019.111592 |
| Mus sp. |
Mus sp. |
Log 1/LD10 |
4.74 |
None |
10.1021/jm00345a015 |
| Oncorhynchus gorbuscha |
Salmon testes DNA |
Activity |
nan |
None |
10.1016/j.ejmech.2019.111592 |
| Oryctolagus cuniculus |
Aldehyde oxidase |
Ki |
60.0 |
nM |
10.1021/jm100888d |
| Oryza sativa Japonica Group |
Os06g0676700 protein |
Potency |
44668.4 |
nM |
None |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
600.0 |
nM |
10.1021/jm00036a014 |
| Rattus norvegicus |
Aldehyde oxidase |
IC50 |
6400.0 |
nM |
10.1021/jm100888d |
| Rattus norvegicus |
Aldehyde oxidase |
Ki |
3000.0 |
nM |
10.1021/jm100888d |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
18999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
6309.6 |
nM |
None |
| Rattus norvegicus |
Muscarinic acetylcholine receptor M1 |
Potency |
10000.0 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
18887.6 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
19952.6 |
nM |
None |
| Rattus norvegicus |
Thioredoxin reductase 1, cytoplasmic |
Potency |
31622.8 |
nM |
None |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Activity |
2.7 |
ug |
10.1021/np9701438 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Activity |
8.2 |
ug |
10.1021/np9701438 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Activity |
20.0 |
ug |
10.1021/np9701438 |
| Saccharomyces cerevisiae |
Saccharomyces cerevisiae |
Potency |
18356.4 |
nM |
None |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Log 1/C |
4.7 |
None |
10.1021/jm00177a011 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Log D50 |
1.4 |
None |
10.1021/jm00177a011 |
| Salmonella enterica subsp. enterica serovar Typhimurium |
Salmonella typhimurium |
Log M50 |
2.13 |
None |
10.1021/jm00177a011 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-1.981 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
-0.52 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
21.46 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
-0.1254 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
-4.19 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.06 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.2 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.04 |
% |
10.6019/CHEMBL4495565 |
| Staphylococcus aureus |
Staphylococcus aureus |
Activity |
nan |
None |
10.1016/j.bmc.2016.08.003 |
| Staphylococcus aureus |
Teichoic acid D-alanyltransferase |
MIC |
2.0 |
ug.mL-1 |
10.1016/j.bmc.2016.08.003 |
| Staphylococcus aureus |
Teichoic acid D-alanyltransferase |
MIC |
32.0 |
ug.mL-1 |
10.1016/j.bmc.2016.08.003 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/jm00126a025 |
| None |
ADMET |
CL |
4.3 |
mL.min-1.kg-1 |
10.1124/dmd.108.020479 |
| None |
ADMET |
Fluoroscence |
63.73 |
% |
10.1021/jm00126a025 |
| None |
ADMET |
IC50 |
0.3 |
ug.mL-1 |
10.1021/jm00126a025 |
| None |
ADMET |
IC50 |
240.0 |
nM |
10.1021/jm00048a017 |
| None |
ADMET |
IC50 |
2000.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| None |
ADMET |
IC50 |
4200.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| None |
ADMET |
IC50 |
7700.0 |
nM |
10.1021/jm100888d |
| None |
ADMET |
Log K |
5.57 |
None |
10.1021/jm00374a020 |
| None |
ADMET |
MRT |
6.2 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
pka |
7.43 |
None |
10.1021/jm00392a009 |
| None |
ADMET |
pKa |
7.43 |
None |
10.1021/jm00365a014 |
| None |
ADMET |
Rm |
0.18 |
None |
10.1021/jm00177a011 |
| None |
ADMET |
T1/2 |
0.03 |
hr |
10.1021/jm00365a014 |
| None |
ADMET |
T1/2 |
4.7 |
hr |
10.1124/dmd.108.020479 |
| None |
ADMET |
T1/2 |
13.2 |
None |
10.1021/jm00137a009 |
| None |
ADMET |
T1/2 |
24.0 |
hr |
10.1021/jm00166a022 |
| None |
ADMET |
T1/2 |
336.0 |
hr |
10.1021/jm00166a022 |
| None |
ADMET |
Vdss |
1.6 |
L.kg-1 |
10.1124/dmd.108.020479 |
| None |
F460pv8/eto |
IC50 |
40.0 |
nM |
10.1021/jm9909490 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
3.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
NON-PROTEIN TARGET |
Blockage activity |
nan |
None |
10.1021/jm00166a022 |
| None |
NON-PROTEIN TARGET |
Fu |
0.029 |
None |
10.1124/dmd.108.020479 |
| None |
NON-PROTEIN TARGET |
GI50 |
229.09 |
nM |
10.1016/j.bmc.2008.07.069 |
| None |
NON-PROTEIN TARGET |
GI50 |
440.0 |
nM |
10.1016/j.bmc.2009.11.012 |
| None |
NON-PROTEIN TARGET |
GI50 |
440.0 |
nM |
10.1021/jm200046z |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
10.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
41.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
IC50 |
12.0 |
nM |
10.1021/jm970044r |
| None |
NON-PROTEIN TARGET |
IC50 |
20.0 |
nM |
10.1021/jm970044r |
| None |
NON-PROTEIN TARGET |
IC50 |
37.0 |
nM |
10.1021/jm970044r |
| None |
NON-PROTEIN TARGET |
IC50 |
40.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| None |
NON-PROTEIN TARGET |
IC50 |
80.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| None |
NON-PROTEIN TARGET |
IC50 |
400.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| None |
NON-PROTEIN TARGET |
IC50 |
740.0 |
nM |
10.1016/j.bmc.2008.07.015 |
| None |
NON-PROTEIN TARGET |
IC50 |
930.0 |
nM |
10.1016/j.ejmech.2016.03.066 |
| None |
NON-PROTEIN TARGET |
IC50 |
8800.0 |
nM |
10.1016/j.bmc.2007.10.084 |
| None |
NON-PROTEIN TARGET |
LC50 |
20892.96 |
nM |
10.1016/j.bmc.2008.07.069 |
| None |
NON-PROTEIN TARGET |
Ratio |
4.0 |
None |
10.1021/jm00048a017 |
| None |
NON-PROTEIN TARGET |
TGI |
3388.44 |
nM |
10.1016/j.bmc.2008.07.069 |
| None |
No relevant target |
Index |
-1.2 |
None |
10.1021/jm970232h |
| None |
No relevant target |
LogP |
3.8 |
None |
10.1016/j.ejmech.2009.12.043 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00137a009 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00177a011 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00199a002 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00345a015 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00365a013 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00369a021 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00369a022 |
| None |
No relevant target |
pKa |
7.43 |
None |
10.1021/jm00387a012 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00199a002 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00205a013 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00214a012 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00218a001 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00365a014 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00374a020 |
| None |
No relevant target |
Rm |
0.18 |
None |
10.1021/jm00392a009 |
| None |
Nucleic Acid |
Activity |
48.0 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Activity |
nan |
None |
10.1016/j.bmc.2010.06.006 |
| None |
Nucleic Acid |
Activity |
nan |
None |
10.1016/j.bmc.2010.12.037 |
| None |
Nucleic Acid |
Activity |
nan |
None |
10.1016/j.ejmech.2008.12.011 |
| None |
Nucleic Acid |
Activity |
nan |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
CC50 |
8900.0 |
nM |
10.1021/jm00018a009 |
| None |
Nucleic Acid |
Concentration |
8.8 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Concentration |
12.1 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Concentration |
12.2 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Concentration |
434.0 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Concentration |
437.0 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Concentration |
439.0 |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
K |
2.9 |
None |
10.1021/jm00365a014 |
| None |
Nucleic Acid |
k0 |
2.6 |
M-1 |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
k0 |
2.9 |
M-1 |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Log K |
5.57 |
None |
10.1021/jm00352a027 |
| None |
Nucleic Acid |
Log K |
5.57 |
None |
10.1021/jm00365a013 |
| None |
Nucleic Acid |
Log K |
5.57 |
None |
10.1021/jm00369a021 |
| None |
Nucleic Acid |
Log K |
5.57 |
None |
10.1021/jm00369a022 |
| None |
Nucleic Acid |
Log K |
5.65 |
None |
10.1021/jm00365a013 |
| None |
Nucleic Acid |
Log K |
5.65 |
None |
10.1021/jm00369a021 |
| None |
Nucleic Acid |
Log KAT |
5.57 |
None |
10.1021/jm00164a054 |
| None |
Nucleic Acid |
Log Kd |
5.14 |
None |
10.1021/jm00370a007 |
| None |
Nucleic Acid |
Q |
4.5 |
uM |
10.1021/jm00018a009 |
| None |
Nucleic Acid |
Q |
25.0 |
uM |
10.1021/jm00018a009 |
| None |
Nucleic Acid |
Relative amplitude |
25.0 |
% |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Relative amplitude |
75.0 |
% |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Relative amplitude |
nan |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Time constant |
2.0 |
ms |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Time constant |
6.0 |
ms |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Time constant |
nan |
None |
10.1021/jm00169a039 |
| None |
Nucleic Acid |
Tm shift |
4.0 |
degrees C |
10.1021/jm00018a009 |
| None |
Unchecked |
Activity |
-10.0 |
% |
None |
| None |
Unchecked |
Activity |
1.8 |
% |
None |
| None |
Unchecked |
Activity |
64.0 |
% |
None |
| None |
Unchecked |
Activity |
65.0 |
% |
None |
| None |
Unchecked |
Activity |
79.0 |
% |
None |
| None |
Unchecked |
Activity |
84.0 |
% |
None |
| None |
Unchecked |
Activity |
92.0 |
% |
None |
| None |
Unchecked |
Activity |
109.0 |
% |
None |
| None |
Unchecked |
Activity |
110.0 |
% |
None |
| None |
Unchecked |
Activity |
113.0 |
% |
None |
| None |
Unchecked |
Activity |
131.0 |
% |
None |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmc.2008.11.072 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2013.07.048 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.ejmech.2017.03.048 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/acs.jmedchem.7b01297 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm00137a004 |
| None |
Unchecked |
Activity |
nan |
None |
10.1021/jm900627v |
| None |
Unchecked |
Activity |
nan |
None |
10.1039/c9md00597h |
| None |
Unchecked |
Blockage activity |
nan |
None |
10.1021/jm00166a022 |
| None |
Unchecked |
C50 |
10.8 |
uM |
10.1021/jm00205a013 |
| None |
Unchecked |
Delta Tm |
0.0 |
degrees C |
10.1021/jm070587t |
| None |
Unchecked |
Hepatotoxicity (acute) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
2.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
4.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC20 |
3.3 |
10'-6M |
None |
| None |
Unchecked |
IC50 |
6260.0 |
nM |
None |
| None |
Unchecked |
IC50 |
6430.0 |
nM |
10.1016/j.bmc.2017.04.030 |
| None |
Unchecked |
IC50 |
10000.0 |
nM |
10.1016/j.bmc.2016.01.011 |
| None |
Unchecked |
IC50 ratio |
74.0 |
None |
10.1021/jm970044r |
| None |
Unchecked |
IC50 ratio |
85.0 |
None |
10.1021/jm970044r |
| None |
Unchecked |
Inhibition |
22.0 |
% |
None |
| None |
Unchecked |
Inhibition |
56.9 |
% |
10.1016/j.bmc.2017.04.030 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2016.08.003 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmc.2017.04.030 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.bmcl.2021.127815 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2016.09.004 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1016/j.ejmech.2017.01.003 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/acs.jmedchem.5b01284 |
| None |
Unchecked |
Inhibition |
nan |
% |
10.1021/jm00166a022 |
| None |
Unchecked |
K |
nan |
None |
10.1021/jm00048a017 |
| None |
Unchecked |
MIC |
1.0 |
ug.mL-1 |
10.1016/j.bmc.2016.08.003 |
| None |
Unchecked |
Potency |
730.5 |
nM |
None |
| None |
Unchecked |
Potency |
15848.9 |
nM |
None |
| None |
Unchecked |
Ratio |
0.082 |
None |
10.1021/jm00205a013 |
| None |
Unchecked |
Ratio |
0.68 |
None |
10.1021/jm00121a007 |
| None |
Unchecked |
Ratio |
0.9 |
None |
10.1021/jm00121a007 |
| None |
Unchecked |
Ratio |
1.0 |
None |
10.1016/0960-894X(95)00300-I |
| None |
Unchecked |
Ratio |
3.6 |
None |
10.1021/jm00159a035 |
| None |
Unchecked |
Ratio |
3.6 |
None |
10.1021/jm00387a012 |
| None |
Unchecked |
Ratio |
4.0 |
None |
10.1021/jm00022a016 |
| None |
Unchecked |
Ratio CC50/IC50 |
101.6 |
None |
10.1016/j.ejmech.2019.111592 |
| None |
Unchecked |
Ratio CC50/IC50 |
104.94 |
None |
10.1016/j.ejmech.2019.111592 |